Busey Wealth Management Regeneron Pharmaceuticals, Inc. Transaction History

Busey Wealth Management

  • $3 Billion
  • Q3 2024

A detailed history of Busey Wealth Management transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Busey Wealth Management holds 1,563 shares of REGN stock, worth $1.12 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,563
Previous 1,790 12.68%
Holding current value
$1.12 Million
Previous $1.88 Million 12.65%
% of portfolio
0.05%
Previous 0.07%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$1024.09 - $1201.76 $232,468 - $272,799
-227 Reduced 12.68%
1,563 $1.64 Million
Q2 2024

Jul 23, 2024
SELL
$883.2 - $1071.19 $81,254 - $98,549
-92 Reduced 4.89%
1,790 $1.88 Million
Q1 2024

Apr 23, 2024
SELL
$902.69 - $993.35 $103,809 - $114,235
-115 Reduced 5.76%
1,882 $1.81 Million
Q4 2023

Jan 25, 2024
BUY
$775.18 - $881.7 $12,402 - $14,107
16 Added 0.81%
1,997 $1.75 Million
Q3 2023

Oct 23, 2023
SELL
$692.45 - $844.37 $220,891 - $269,354
-319 Reduced 13.87%
1,981 $1.63 Million
Q2 2023

Jul 21, 2023
SELL
$700.03 - $830.35 $36,401 - $43,178
-52 Reduced 2.21%
2,300 $1.65 Million
Q1 2023

Apr 25, 2023
SELL
$680.49 - $826.97 $45,592 - $55,406
-67 Reduced 2.77%
2,352 $1.93 Million
Q4 2022

Jan 23, 2023
SELL
$705.89 - $766.39 $23,294 - $25,290
-33 Reduced 1.35%
2,419 $0
Q3 2022

Oct 24, 2022
SELL
$573.97 - $724.32 $78,633 - $99,231
-137 Reduced 5.29%
2,452 $1.69 Million
Q2 2022

Aug 01, 2022
SELL
$548.35 - $738.84 $212,211 - $285,931
-387 Reduced 13.0%
2,589 $1.53 Million
Q1 2022

Apr 21, 2022
SELL
$595.12 - $698.43 $20,829 - $24,445
-35 Reduced 1.16%
2,976 $2.08 Million
Q4 2021

Jan 25, 2022
SELL
$543.48 - $670.97 $70,108 - $86,555
-129 Reduced 4.11%
3,011 $1.9 Million
Q3 2021

Oct 29, 2021
SELL
$574.03 - $680.96 $190,577 - $226,078
-332 Reduced 9.56%
3,140 $1.9 Million
Q2 2021

Jul 22, 2021
SELL
$472.8 - $558.54 $65,719 - $77,637
-139 Reduced 3.85%
3,472 $1.94 Million
Q1 2021

Apr 20, 2021
SELL
$446.73 - $548.2 $109,448 - $134,309
-245 Reduced 6.35%
3,611 $1.71 Million
Q4 2020

Jan 20, 2021
SELL
$478.3 - $607.98 $76,528 - $97,276
-160 Reduced 3.98%
3,856 $1.86 Million
Q3 2020

Oct 16, 2020
SELL
$544.75 - $658.21 $34,864 - $42,125
-64 Reduced 1.57%
4,016 $2.25 Million
Q2 2020

Jul 21, 2020
SELL
$493.32 - $643.92 $34,039 - $44,430
-69 Reduced 1.66%
4,080 $2.55 Million
Q1 2020

Apr 17, 2020
SELL
$336.18 - $494.43 $6,387 - $9,394
-19 Reduced 0.46%
4,149 $2.03 Million
Q4 2019

Feb 11, 2020
SELL
$274.13 - $376.51 $201,485 - $276,734
-735 Reduced 14.99%
4,168 $1.57 Million
Q3 2019

Nov 12, 2019
BUY
$273.46 - $318.39 $1.34 Million - $1.56 Million
4,903 New
4,903 $1.36 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Busey Wealth Management Portfolio

Follow Busey Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Busey Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Busey Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email